How can we overcome ibrutinib resistance?
Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment
Treating CLL with venetoclax
The influence of the European Research Initiative on CLL (ERIC)
Trial of ibrutinib with bendamustine and rituximab in CLL: results and study design